MAPT and Alzheimer disease: 2.4. Quantitative PCR Performed on NAM Co-Cultures Treated with CSF from AD (Aβ+Tau and Aβ-Tau) and Non-AD (Non-AD) Subjects at 24 h and 48 h, Respectively